|
Join us at the 2026 AAP Annual Meeting in Seattle See the Clinical Highlights at the OsteoGen™ AAP 2026 Corporate Forum: Advancing Science and Clinical Practice with a Novel Biomaterial
OsteoGen™ Corporate Forum
Thursday, October 29th, Room #618, Arch Building Session I: 3:10 PM – 3:55 PM Session II: 4:15 PM – 5:00 PM Joint panel discussion follows Session II, featuring speakers from both sessions. Bring your questions for an interactive Q&A.
What You'll See This Corporate Forum presents real-world clinical highlights from a multi-center, randomized controlled trial conducted through The McGuire Institute's (iMc) practice-based research network. Investigators will report clinical, radiographic, and histologic findings, showing how the OsteoGen Plug® with Bioactive Crystal Technology (BCT) performed across therapeutic indications.
The Research Team Principal investigator Dr. Irina Dragan will be joined in Session I by investigators Michael K. McGuire, DDS, and Rachel Schallhorn, DDS, MS, and in Session II by Brad Landers and Nika Mehrnia, with sessions moderated by Jeanne Ambruster. Together, they'll share clinical highlights demonstrating the advantages of bioactive crystal technology and explore expanded clinical indications where this technology makes a real difference. A panel discussion at the end of Session II brings together speakers from both sessions, offering the opportunity to ask questions and engage directly with several members of the research team.
Why Attend
This forum gives you early access to the clinical highlights behind Bioactive Crystal Technology (BCT). You will see data that is based on clinical science and how it applies to your regenerative work.
Save the Date — OsteoGen™ Corporate Forum Sessions The Corporate Forum is included with your AAP 2026 Annual Meeting registration, so there's no separate sign-up. October 29, 2026, 3:10 PM – 5:00 PM, Arch Building, Room 618.
|
